Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Cardiothorac Surg ; 19(1): 317, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38824602

ABSTRACT

BACKGROUND: To investigate the risk factors of pneumothorax of using computed tomography (CT) guidance to inject autologous blood to locate isolated lung nodules. METHODS: In the First Hospital of Putian City, 92 cases of single small pulmonary nodules were retrospectively analyzed between November 2019 and March 2023. Before each surgery, autologous blood was injected, and the complications of each case, such as pneumothorax and pulmonary hemorrhage, were recorded. Patient sex, age, position at positioning, and nodule type, size, location, and distance from the visceral pleura were considered. Similarly, the thickness of the chest wall, the depth and duration of the needle-lung contact, the length of the positioning procedure, and complications connected to the patient's positioning were noted. Logistics single-factor and multi-factor variable analyses were used to identify the risk factors for pneumothorax. The multi-factor logistics analysis was incorporated into the final nomogram prediction model for modeling, and a nomogram was established. RESULTS: Logistics analysis suggested that the nodule size and the contact depth between the needle and lung tissue were independent risk factors for pneumothorax. CONCLUSION: The factors associated with pneumothorax after localization are smaller nodules and deeper contact between the needle and lung tissue.


Subject(s)
Lung Neoplasms , Pneumothorax , Solitary Pulmonary Nodule , Tomography, X-Ray Computed , Humans , Male , Retrospective Studies , Pneumothorax/etiology , Pneumothorax/diagnostic imaging , Female , Risk Factors , Tomography, X-Ray Computed/methods , Middle Aged , Lung Neoplasms/surgery , Solitary Pulmonary Nodule/diagnostic imaging , Solitary Pulmonary Nodule/surgery , Aged , Adult , Blood Transfusion, Autologous/methods
2.
Sci Rep ; 14(1): 8694, 2024 04 15.
Article in English | MEDLINE | ID: mdl-38622149

ABSTRACT

We aimed to investigate the expression and clinic significance of Rac GTPase Activating Protein 1 (RACGAP1) in human lung adenocarcinoma (LUAD). Online database analysis revealed a significant increase in RACGAP1 mRNA expression among 26 types of tumor tissues, including LUAD tissues. Online database and tissue microarray analyses indicated that RACGAP1 expression was significantly upregulated in LUAD tissues. Genetic variation analysis identified four different genetic variations of RACGAPs in LUAD. Moreover, online database analysis showed that RACGAP1 upregulation was correlated with shorter survival in patients with LUAD. After silencing RACGAP1 expression in A549 cells using siRNA and assessing its protein levels via Western blotting, we found that RACGAP1 knockdown inhibited cell growth and induced apoptosis determined using the Cell Counting Kit-8 assay, colony formation assay, and flow cytometry. Mechanistically, western blot analysis indicated that Bax expression increased, whereas Bcl-2 expression decreased. Moreover, RACGAP1 knockdown attenuated PI3K/AKT pathway activation in lung cancer cells. Taken together, our findings showed that RACGAP1 was overexpressed in LUAD tissues and played an important role in lung cancer by increasing cell growth through the PI3K/AKT signaling pathway. This study suggests recommends evaluating RACGAP1 in clinical settings as a novel biomarker and potential therapeutic target for lung cancer.


Subject(s)
Adenocarcinoma of Lung , Lung Neoplasms , Humans , Lung Neoplasms/pathology , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/metabolism , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction , Adenocarcinoma of Lung/pathology , Cell Proliferation/genetics , Gene Expression Regulation, Neoplastic , Cell Line, Tumor , Cell Movement/genetics
3.
Adv Mater ; : e2407032, 2024 Jul 25.
Article in English | MEDLINE | ID: mdl-39049807

ABSTRACT

Flexible perovskite solar cells (f-PSCs) have emerged as potential candidates for specific mechanical applications owing to their high foldability, efficiency, and portability. However, the power conversion efficiency (PCE) of f-PSC remains limited by the inferior contact between perovskite and flexible buried substrate. Here, an asymmetric π-extended self-assembled monolayer (SAM) (4-(9H-dibenzo[a,c]carbazol-9-yl)butyl)phosphonic acid (A-4PADCB) is reported as a buried substrate for efficient inverted f-PSCs. Employing this design strategy, A-4PADCB exhibits a significant orientation angle away from the surface normal, homogenizing the distribution of contact potentials. This enhancement improves the SAM/perovskite interface quality, controlling the growth of favorable perovskite films with low defect density and slight tensile stress. Integration of A-4PADCB into small-area f-PSCs and large-area flexible perovskite solar modules with an aperture area of 20.84 cm2 achieves impressive PCEs of up to 25.05% and 20.64% (certified 19.51%), respectively. Moreover, these optimized A-4PADCB-based f-PSCs possess enhanced light, thermal, and mechanical stability. This research paves a promising avenue toward the design of SAM-buried substrates with a large orientation angle, regulating perovskite growth, and promoting the commercialization of large-area flexible perovskite photovoltaics.

SELECTION OF CITATIONS
SEARCH DETAIL